The GiveWell Blog

All Against Malaria Foundation Posts

The Research behind Our $276 Million Grant for Malaria Nets in DRC

(updated on: ) | by GiveWell Staff

Malaria kills around 600,000 people annually. Children under five years old in Africa account for about 70% of all malaria deaths worldwide, and around 11% of total malaria deaths are in the Democratic Republic of the Congo (DRC).

As part of our ongoing efforts to scale our research and funding to direct much more money where it can do extraordinary good, GiveWell recently made its largest grant ever: $276 million to fund the purchase and distribution of malaria nets in DRC through the Against Malaria Foundation (AMF). The grant is being funded by Coefficient Giving and donations to GiveWell’s Top Charities Fund.

We estimate this grant will lead to the distribution of around 92 million insecticide-treated nets (ITNs), 46 million of which we think would not otherwise be distributed, and will avert approximately 67,000 deaths.

The research we conducted as part of this grant investigation led us to two key decisions:

  • First, this grant is much larger than our past funding for nets in DRC, enabling the purchase of nets for use across all 26 provinces of DRC from 2027 through 2029 and covering $60 million in distribution costs.
  • Second, the funding will shorten the time between regular net distributions to provide additional protection against malaria in up to five provinces with higher malaria burden.

Read More

Announcing Our Largest Grant to Date

| by GiveWell Staff

GiveWell, with co-funding from Coefficient Giving, recently made our largest grant ever: $276 million to the Against Malaria Foundation (AMF) to support the procurement and distribution of 92 million nets in the Democratic Republic of the Congo (DRC) from 2027 through 2029. We estimate that the nets, 46 million of which we think are additional to what would otherwise be distributed, will avert roughly 67,000 deaths. We have supported AMF’s work for more than 15 years, and the insecticide-treated nets it procures and distributes remain one of the most cost-effective ways we’ve found to save lives.

This grant, which involved a more rigorous investigation process than most, is part of a larger story about scaling our team and systems to handle substantially more funding while deepening our research rigor. Last year, we directed more than $400 million to highly cost-effective programs to save and improve lives and, this year, we expect our grantmaking to approach, and possibly exceed, $1 billion. This increase in grantmaking aims to meet global needs faster and more effectively.

In this episode, GiveWell co-founder and CEO Elie Hassenfeld speaks with Senior Program Officer Alex Bowles about the questions the team set out to answer during the grant investigation.

Read More

Podcast Episode 29: Behind the Analysis — Assessing Past Malaria Nets Grants

(updated on: ) | by GiveWell Staff

GiveWell’s research doesn’t end once we’ve made a grant. We evaluate a subset of completed grants, comparing what we thought would happen to what actually took place, then try to use what we learn to improve our future funding decisions. Over the past year, we’ve formalized and expanded this work, publishing comprehensive “lookbacks” for select grants.

A recent lookback on grants GiveWell made to fund insecticide-treated net distributions supported by the Against Malaria Foundation (AMF) in the Democratic Republic of Congo (DRC) illustrates the growing capacity of GiveWell’s research team. We drew on multiple independent data sources, funded qualitative interviews to gather more information, and conducted a novel empirical analysis to deepen our confidence.

In this episode, based on a conversation originally aired on GiveWell’s internal podcast for staff*, GiveWell’s co-founder and CEO Elie Hassenfeld provides additional context while GiveWell’s Chief Research and Program Officer Teryn Mattox dives deep into the details with Program Director Alex Cohen and Researcher Steven Brownstone, examining how we conducted the lookback, what we found, and how what we learned may shape our future nets grantmaking.

Read More

Our recommendations for giving in 2022

| by Miranda Kaplan

We wrote back in July that we expected to be funding-constrained this year. That remains true as we approach the end of the year, putting us in the unusual position of leaving impact on the table.

We’ve set a goal of raising $600 million in 2022, but our research team has identified $900 million in highly cost-effective funding gaps. That leaves $300 million in funding gaps unfilled. By donating this year, you can help us not only meet but exceed our goal—and say yes to more excellent opportunities to save and improve lives.

Additionally, our giving guidance for donors has changed this year. For the first time, our top recommendation is to give to our new All Grants Fund, which we allocate to any need that meets our cost-effectiveness bar. We think it’s the best bet for donors who want to support the most promising opportunities we’ve found to help people, regardless of program or location. And it reflects our current views on how we can best meet our goal of maximizing global well-being—by taking advantage of every path to impact, whether that’s funding top charities, seeding and scaling newer programs, or funding research.

Read More

Our recommendations for giving in 2021

(updated on: ) | by Ben Bateman

You can have a remarkable impact by supporting cost-effective, evidence-based charities.

Just looking at the approximately $100 million GiveWell had discretion to grant in 2020—a subset of all the money we directed to the charities we recommend—the impact of our donors is impressive. We estimate these grants will:

  • Save more than 24,000 lives
  • Treat over 6 million children with a full course of antimalarial medication
  • Provide vitamin A supplementation to over 8.6 million children
  • Deliver over 4.4 million long-lasting insecticide-treated nets (LLINs) to protect against malaria
  • Vaccinate 118,000 children
  • Treat over 11.4 million children for parasitic worms

Read More

Initial thoughts on malaria vaccine approval

(updated on: ) | by Julie Faller

The World Health Organization (WHO) recently recommended the widespread use of the malaria vaccine RTS,S/AS01 for children. It provides an additional, effective tool to fight malaria. This is great news!

We’ve been following this vaccine’s development for years and, in the last few months, have been speaking with organizations involved in its development and potential wider rollout.

Our work on RTS,S (and other malaria vaccines) is ongoing, and we might significantly update our views in the near future. But because we’ve been following its progress, we’re sharing some initial thoughts.

Read More

Next Page »